ArticlesImmunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study
Introduction
In 2013, HIV-infected patients accounted for 13% of 9·0 million tuberculosis cases and 24% of 1·5 million tuberculosis-associated deaths worldwide.1 Initiation of antiretroviral therapy (ART) during tuberculosis treatment can decrease mortality in HIV-infected individuals.2 The need for ART is particularly urgent in patients with advanced HIV, because patients with the lowest CD4 T-cell counts have improved survival when ART is started within the first few weeks of anti-tubercular therapy.3, 4, 5 Nonetheless, patients with advanced HIV and tuberculosis have a persistently high risk of death despite starting therapy for both diseases. For example, 120 (18%) of 661 patients and 55 (7%) of 783 patients in two trials of ART timing in patients with HIV and tuberculosis died within 48 weeks despite starting both ART and anti-tubercular therapy (M Kendall, Harvard School of Public Health, personal communications).3, 5
Early ART initiation after tuberculosis treatment is also associated with an increased risk of paradoxical tuberculosis-associated immune reconstitution inflammatory syndrome (IRIS),3, 4, 5, 6, 7 characterised by pathological inflammation after ART initiation in patients concurrently treated for tuberculosis.8, 9, 10, 11, 12, 13 Although mortality from tuberculosis-associated IRIS is low,14 morbidity can be substantial.7, 14, 15 Studies of outcomes in patients with HIV and tuberculosis have frequently focused on tuberculosis-associated IRIS while excluding early deaths; as such, mechanisms of early mortality after ART in patients with HIV and tuberculosis are largely unknown. However, failure to recover CD4 cell counts despite virological suppression has been associated with early death after ART initiation in adults with advanced HIV and tuberculosis.16 This finding is notable because the diminished cellular immune recovery reported in early mortality16 contrasts with the more rapid cellular immune responses often noted in patients with tuberculosis-associated IRIS,8, 12, 13, 17 suggesting that the underlying immunopathogenesis for tuberculosis-associated IRIS and early mortality differ. Understanding of the risk factors for these outcomes is important, because interventions designed to prevent tuberculosis-associated IRIS could increase early mortality if the immunological processes, such as rapid immune recovery, driving that disorder are associated with survival. In view of these differences, we postulated that patients who go on to develop tuberculosis-associated IRIS would differ from those who die early after ART initiation in terms of immune activation and recovery before and early after ART initiation.
We investigated the relation of clinical variables and immunological characteristics before and 4 weeks after ART initiation to risk of non-traumatic death (early mortality) and paradoxical tuberculosis-associated IRIS in adults with advanced HIV and tuberculosis.
Section snippets
Study design
We did a prospective cohort study at 22 public clinics and Princess Marina Hospital (the main public hospital) in Gaborone, Botswana, with previously described methods.16 Eligible patients (aged ≥21 years) were HIV-infected, ART-naive citizens of Botswana with pre-ART CD4 cell counts of 125 cells per μL or less, a new diagnosis of pulmonary tuberculosis, and plans to initiate ART within 2 months of starting standard anti-tuberculosis therapy.18 Diagnosis of pulmonary tuberculosis required a
Results
Between Nov 12, 2009, and July 3, 2013, we enrolled 201 participants. Before ART initiation, 31 (15%) patients left the study: three withdrew, ten transferred out, five died, and 13 were discontinued from the study because of failure to follow study procedures, leaving 170 (85%) patients for analysis. The median CD4 cell count of included participants was 60 cells per μL (IQR 31–90), nearly three-quarters of patients had smears positive for acid-fast bacilli or GeneXpert assays positive for
Discussion
Our findings show that individuals who had early mortality or paradoxical tuberculosis-associated IRIS had substantially different pre-ART biomarker concentrations compared with those with uncomplicated immune recovery. Furthermore, patients with IRIS and early mortality had rapid increases in immune activation and inflammation early during ART, but differed substantially in terms of the magnitude of early cellular immune recovery after ART initiation.
Although several studies8, 9, 10, 11, 12, 22
References (40)
- et al.
Immune reconstitution inflammatory syndrome in patients starting antiretroviral therapy for HIV infection: a systematic review and meta-analysis
Lancet Infect Dis
(2010) - et al.
Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings
Lancet Infect Dis
(2008) Role of interleukin-12 family cytokines in the cellular response to mycobacterial disease
Int J Infect Dis
(2010)Global tuberculosis report 2014
- et al.
Timing of initiation of antiretroviral drugs during tuberculosis therapy
N Engl J Med
(2010) - et al.
Timing of antiretroviral therapy for HIV-1 infection and tuberculosis
N Engl J Med
(2011) - et al.
Integration of antiretroviral therapy with tuberculosis treatment
N Engl J Med
(2011) - et al.
Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis
N Engl J Med
(2011) - et al.
Tuberculosis immune reconstitution inflammatory syndrome in A5221 STRIDE: timing, severity, and implications for HIV-TB programs
J Acquir Immune Defic Syndr
(2014) - et al.
The immune reconstitution inflammatory syndrome after antiretroviral therapy initiation in patients with tuberculosis: findings from the SAPiT trial
Ann Intern Med
(2012)
Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients
AIDS
Circulating inflammatory biomarkers can predict and characterize tuberculosis-associated immune reconstitution inflammatory syndrome
AIDS
Paradoxical tuberculosis immune reconstitution inflammatory syndrome (TB-IRIS) in HIV patients with culture confirmed pulmonary tuberculosis in India and the potential role of IL-6 in prediction
PLoS One
Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome
Eur Respir J
Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome
Am J Respir Crit Care Med
Tuberculosis-associated immune restoration syndrome in HIV-1-infected patients involves tuberculin-specific CD4 Th1 cells and KIR-negative gammadelta T cells
J Immunol
Frequency, severity and duration of immune reconstitution events in HIV-related tuberculosis
Int J Tuberc Lung Dis
Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis
J Infect Dis
TB-IRIS after initiation of antiretroviral therapy is associated with expansion of preexistent Th1 responses against Mycobacterium tuberculosis antigens
J Acquir Immune Defic Syndr
Treatment of tuberculosis: guidelines, 4th edn
Cited by (70)
Food Insecurity and Undernutrition Are Associated With Distinct Immunologic Profiles in People With Tuberculosis and Advanced HIV Starting Antiretroviral Therapy
2024, Journal of Acquired Immune Deficiency Syndromes